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However, the degree of NIT predicted by a simple linear
model is insufficient to explain the development of high-
grade occlusive lesions in areas of low τ. The purpose of
this study was to examine the effects of very low τ (< 2
dyne/cm2) in a new model of peripheral vein grafting with
reliable patency even at very low flow.
METHODS
Animal operations. Male New Zealand White rabbits
(3-3.5 kg) were anesthetized through intramuscular injec-
tion with ketamine hydrochloride (40 mg/kg) and
xylazine (5 mg/kg). Anesthesia was maintained with endo-
tracheal intubation and inhaled halothane. Antibiotic pro-
phylaxis was provided with enrofloxacin (10 mg/kg) daily.
Using sterile technique, the external jugular vein was
exposed, and heparin was given to the animal as an antico-
agulant (200 U/kg intravenously). The isolated vein seg-
ment was excised and bivalved. The ipsilateral common
carotid artery was exposed and the distal cranial thyroid
branch identified (Fig 1, A). A 1.5-cm longitudinal arteri-
otomy was made in the common carotid artery proximal to
the cranial thyroid branch. The arteriotomy was closed by
A proposed but unproven mechanism of peripheral
vein graft failure invokes the pathway of low shear stress
(τ) → smooth muscle cell (SMC) activation and prolifera-
tion → neointimal thickening (NIT) → neointimal hyper-
plasia → stenosis → thrombosis. Clear evidence exists for
a relationship between low τ (5-15 dyne/cm2) and SMC
proliferation and NIT in experimental vein grafts.1-14
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Objective: Previous studies demonstrating a correlation between low shear stress (τ = 5-15 dyne/cm2) and experimen-
tal vein graft neointimal thickening (NIT) support the role of low τ in vein graft failure. However, a simple linear rela-
tionship between low τ and NIT would underestimate the degree of NIT evident in high-grade occlusive lesions of
failing human vein grafts. In this study we used a new experimental model that maintains patency at low τ (< 2
dyne/cm2), to delineate possible deviations from linearity in the low τ → NIT hypothesis.
Methods: Thirty-two New Zealand White rabbits underwent creation of a common carotid vein patch with a segment
of ipsilateral external jugular vein. Very low τ was created in 13 patches by ligation of the distal common carotid artery,
leaving the only outflow through a small muscular branch. Normal τ was created in 11 patches by leaving the common
carotid artery outflow intact. High τ was created in eight patches by ligation of the contralateral common carotid
artery. Six patches were harvested after 2 weeks for measurement of cell cycle entry by proliferating cell nuclear anti-
gen (PCNA) immunohistochemistry. The remaining 26 patches were harvested after 4 weeks, perfusion fixed, and
excised for morphometric analysis.
Results: Mean blood flow and τ at implantation ranged from 0.5 to 41 mL/min and 0.07 to 15 dyne/cm2, respectively.
At the time of harvest, 30 of 32 patches remained patent, and the artificially created aberrations in blood flow were
maintained (range, 0.7-41 mL/min). After 2 weeks PCNA immunohistochemistry showed a significantly higher level
of cell cycling in patches exposed to low τ (40 ± 5 vs 1.6 ± 0.3 PCNA-positive cells per high-power field; P < .001),
which is equivalent to approximately 20% of the total cells present. In patches harvested after 4 weeks, NIT ranged
from 42 to 328 µm and significantly correlated with mean τ at implantation. Patches with very low τ exhibited histo-
logic characteristics similar to those of failing human bypass grafts, including laminar thrombus and flow-limiting
luminal stenosis. The relationship between τ and NIT was nonlinear in that extremely low τ (< 2 dyne/cm2) resulted
in NIT beyond that predicted by a simple linear correlation (P = .003).
Conclusion: Extremely low τ (< 2 dyne/cm2) stimulates high rates of smooth muscle cellular proliferation in arterial-
ized vein patches. NIT is accelerated in these regions of low τ far beyond that predicted by a simple linear model. The
nonlinear nature of the cellular proliferative response and NIT at τ less than 2 dyne/cm2 may explain the rapid pro-
gression of neointimal lesions in failing bypass grafts. (J Vasc Surg 2001;34:90-7.)
means of external jugular vein patch angioplasty with run-
ning 8-0 polypropylene suture (Davis-Geck TE-145;
Manatee, Puerto Rico) under 4.5× loupe magnification.
Patches were created such that the final reconstruction
diameter ranged 1.5 to 3 times that of the native artery.
Normal flow and shear were maintained in 11 patches (Fig
1, B). Low shear stress was created in 13 patches by liga-
tion of the ipsilateral common carotid artery just distal to
the cranial thyroid branch (Fig 1, C). Finally, high shear
was created in eight patches by ligation of the contralateral
common carotid artery (with resultant increased ipsilateral
carotid artery flow; Fig 1, D). The combination of differ-
ent reconstruction diameters and flow rates created a wide
range of mean τ, including very low τ (< 2 dyne/cm2) in
many animals (see the “Results” section).
Intra-arterial pressure was monitored with a 22-gauge
catheter placed in the central ear artery (Hewlett-Packard
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78534B; Palo Alto, Calif). Blood flow was measured with
ultrasonic transit-time flowimetry (HT 207; Transonics
Systems, Inc, Ithaca, NY). After creation of the vein patch,
blood flow was allowed to stabilize for 10 minutes; then,
simultaneous pressure and flow waveforms were recorded
for 10 seconds at 200 Hz with a digital data acquisition
system. Length and diameter of the patch as well as diam-
eter of the proximal native artery were measured and
recorded with digital calipers (CD-6”; Mitutoyo Corp,
Osaka, Japan). The incision was closed in two layers with
3-0 polyglactin (subcutaneous tissue) and 4-0 polyglactin
(skin). Anticoagulation was not reversed.
Immunohistochemistry. After 2 weeks, three ani-
mals in the low-shear group and three animals in the nor-
mal-shear group were reanesthetized, and the vein patches
were reexposed. Intra-arterial pressure and blood flow
through the patch were again measured and recorded.
Fig 1. Experimental model of vein patch angioplasty in CCA. A, Normal anatomy. B, Control vein patch. C, Low τ vein patch created
by ligation of ipsilateral CCA. D, High τ patch created by ligation of contralateral CCA. CTA, Cranial thyroid artery; CCA, common
carotid artery; EJV, external jugular vein; SMM, sternomastoid muscle.
After the animals were sacrificed, the vein patches were
perfusion fixed with 1.25% glutaraldehyde at 120 mm Hg
for 10 minutes. The vein patch was divided into three sec-
tions starting 1 mm distal to the beginning of the patch
and ending 1 mm proximal to its end point. Specimens
were dehydrated to 100% ethanol and were paraffin
embedded. Five-µm thick sections were cut from each of
the portions of the patch, deparaffinized, and rehydrated
to phosphate-buffered saline (PBS). Immunohistochem-
ical staining was performed for proliferating cell nuclear
antigen (PCNA) to quantify the percentage of actively
cycling cells within the media and intima. Sections were
incubated with anti-PCNA (1:100 dilution; Nova
Biochem, La Jolla, Calif) in a humidified chamber at 6°C
overnight. After they were rinsed with PBS, the sections
were stained by means of the ABC method (VectaStain
Elite ABC kit; Vector Laboratories Inc, Burlingame, Calif)
according to the manufacturer’s instructions. Sections
were incubated with a biotinylated secondary antibody
(antimouse immunoglobulin G [IgG]) for 1 hour at room
temperature. After they were rinsed with PBS, the sections
were exposed to 0.3% H2O2 for 10 minutes to inhibit
endogenous peroxidase activity. The sections were then
incubated with the ABC reagent (Avidin-Biotin Complex;
Vector Laboratories Inc) for 1 hour at room temperature.
Incubation in diaminobenzidine results in the develop-
ment of brown precipitate, indicating positive staining.
The sections were counterstained with methyl green,
dehydrated, and mounted for visualization. They were
analyzed by counting the number of positive cells per
high-power field (HPF) in five evenly spaced 400× fields
from the venous portion of each section. A total of 15
HPFs were counted from the three tissue segments of
each reconstruction.
Additional sections were stained for smooth muscle
myosin heavy chain and smoothelin, a cytoskeletal protein
specific for smooth muscle cells (SMCs),15 to identify the
cell type composing the neointima. Sections were stained
with mouse monoclonal IgG specific for smoothelin or
rabbit polyclonal IgG specific for smooth muscle myosin
heavy chain (Biomedical Technologies Inc, Stoughton,
Mass). Immunoreactivity was intensified with three
microwave treatments for 5 minutes in citrate buffer.
Biotinylated goat antimouse or antirabbit antibody
(Dako, Copenhagen, Denmark) was used as secondary
antibodies.
Morphometric and statistical analysis. After 4
weeks, the remaining animals were sacrificed and hemody-
namic data recorded as above. Sections were stained with
the Weigert–van Gieson technique to highlight the inter-
nal elastic lamina. Sections were analyzed with digital
planimetry (Adobe Photoshop 5.0; Adobe Systems Inc,
San Jose, Calif). NIT, defined as the distance between the
internal elastic lamina and lumen, was measured at 10
points evenly spaced over the vein patch. The area encom-
passed by the internal elastic lamina and the lumen area
was measured and their ratio used to calculate area and
diameter stenosis.
Mean τ was calculated as 32µQ/πd3, where µ indi-
cates viscosity of blood (0.035 poise); Q, mean blood flow
(cm3/s); and d, measured patch diameter. Comparisons
between groups were made with the use of analysis of vari-
ance with the Bonferroni correction. The relationships
between variables were evaluated with linear and logarith-
mic regression (SPSS for Windows, Release 8.0.0; SPSS
Inc, Chicago, Ill) with a P value of .05 or less considered
significant.
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Fig 2. Ultrasound transit-time flow waveforms of vein patches
with high, normal, and low flow.
Fig 3. PCNA immunohistochemistry in high τ (A) and low τ (B)
vein patches harvested after 2 weeks. Note numerous positively
staining cells (brown pigment) and NIT in B. Magnification ×
400.
RESULTS
All six patches harvested after 2 weeks were patent.
Mean flow at implantation ranged from 0.4 to 1.8
mL/min in the low-flow group and 20 to 52 mL/min in
the normal-flow group (Fig 2). This corresponded to a
mean τ less than 1 dyne/cm2 in all low-flow patches and
more than 10 dyne/cm2 in all normal-flow patches (Table
I). PCNA immunohistochemistry revealed an average of
40 ± 5 positive cells per HPF in the low τ patches and 1.6
± 0.3 positive cells per HPF in the normal τ patches at 2
weeks (P < .001; Fig 3). By 4 weeks, positive cells were
nearly undetectable in both groups (low τ 1.4 ± 0.2 cells
per HPF, normal τ 0.7 ± 0.1 cells per HPF). The cells of
the neointima stained strongly for both smooth muscle
myosin heavy chain and smoothelin, confirming their
medial SMC origin (Fig 4).
After 4 weeks, two patches in the very low-flow group
were occluded. The remaining 24 patches were patent and
subsequently analyzed. Mean flow at implantation ranged
from 0.6 to 41 mL/min. This created a range of τ values
from 0.1 to 13 dyne/cm2. At the time of harvest, the
hemodynamic conditions created at implantation were
largely preserved with mean flow ranging from 0.7 to 41
mL/min (Table II).
In the high τ constructs, only the vein patch exhibited
NIT: the artery appeared histologically normal (Fig 5). In
contrast, low τ generated significant and reproducible
NIT, which affected not only the vein patch but also the
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arterial half of the construct. This produced significant
luminal reduction (28%-33%) and diameter stenoses of up
to 25%. Mean τ at implantation correlated significantly
with the degree of NIT measured after 4 weeks (Fig 6). At
τ less than 1 dyne/cm2 the relationship became nonlinear
with a dramatic increase in NIT far above that predicted
by a linear correlation.
DISCUSSION
The purpose of this study was to examine the effects
of extremely low levels of shear stress (τ) on cellular pro-
liferation and NIT in a new model of arterialized vein.
Shear stress is known to play a key role in the behavior of
vascular tissue in response to hemodynamic stress. Normal
arteries with τ of 10 to 70 dyne/cm2 remodel in response
to high shear by dilation and thinning,16 whereas chroni-
cally low shear leads to intimal thickening and contrac-
tion.17,18 Low shear stress enhances the hyperplastic
response to vessel injury after balloon angioplasty.19 Areas
of low shear and flow separation induce mass transfer and
atherosclerosis,20 and the shear stress hypothesis remains
one of the prevailing theories of atherogenesis.21,22
Like arteries, vein grafts respond to changes in shear in
a fairly predictable manner. As early as 1906 in the Hull
Physiologic Laboratories of the University of Chicago,
Alexis Carrel23 noted that biterminally transplanted veins
became “enormously thickened” after only 15 days. That
this thickening response, largely stimulated by increased
Table I. Hemodynamic profile in vein patches harvested after 2 weeks
Normal τ (n = 3) Low τ (n = 3)
Implantation
Mean blood flow (mL/min) 34 ± 7 1.2 ± 0.4*
Mean blood pressure (mm Hg) 51 ± 8 39 ± 6
Mean τ (dyne/cm2) 13 ± 0.5 0.5 ± 0.2*
Harvest
Mean blood flow (mL/min) 32 ± 3 1.4 ± 0.6*
Mean blood pressure (mm Hg) 44 ± 4 48 ± 5
Mean τ (dyne/cm2) 12 ± 3 0.9 ± 0.5*
*P < .05 compared with normal τ.
Table II. Hemodynamic profile and morphometry of vein patches harvested after 4 weeks
Low τ (n = 8) Normal τ (n = 8) High τ (n = 8)
Implantation
Mean blood pressure (mm Hg) 51 ± 3 45 ± 4 52 ± 6
Mean blood flow (mL/min) 2.3 ± 0.5 21 ± 3* 26 ± 3*
Mean τ (dyne/cm2) 0.5 ± 0.2 4.3 ± 1.7* 5.2 ± 1.6*
Harvest
Mean blood pressure (mm Hg) 56 ± 3 56 ± 4 53 ± 3
Mean blood flow (mL/min) 3.1 ± 0.7 23 ± 3* 32 ± 3*
Mean τ (dyne/cm2) 2.0 ± 1.6 4.5 ± 1.8 16 ± 7*
Mean NIT (µm) 230 ± 43 114 ± 10 76 ± 10*
*P < .05 compared with low τ.
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Fig 4. Rabbit external jugular vein (top row), carotid artery (middle row), and 4-week low-flow vein patch (bottom row; note round
suture artifacts at vein-artery junction). Stains for elastin-collagen (left column), smooth muscle myosin heavy chains (middle column),
and smoothelin (right column). Note high degree of NIT in vein patch reconstruction (bottom row) with expression of smooth muscle
proteins including myosin heavy chains (h) and smoothelin (i). Magnification × 200.
Fig 5. Rabbit external jugular vein patches exposed to high τ (left panels) and low τ (right panels) harvested after 4 weeks. Sections are
shown in whole mount (A, B) along with details of arterial half (C, D) and venous half (E, F) of reconstruction. Note profound inti-
mal hyperplastic response in vein patch exposed to long-term low τ (right panels). Weigert–van Gieson stain, magnification × 40.
wall tension,4,24,25 could be modulated by flow has been
known for more than 40 years. Vlodaver and Edwards,9 in
1971, theorized that vein grafts tended to form more pro-
nounced neointimal lesions when placed proximal to dis-
tal arterial stenoses. In the experimental animal, many
different investigators using a variety of ingenious tech-
niques to augment or attenuate blood flow have consis-
tently demonstrated that long-term reduced levels of flow
and shear lead to greater amounts of NIT in vein
grafts.3,5,6,10-14,26
Although greater NIT in experimental vein grafts can
be generated by long-term low flow, the actual amount of
thickening and overall SMC mass is meager and in no way
histologically resembles the occlusive lesions of failing
human bypass grafts. In fact, the most popular experimen-
tal model of vein graft neointimal hyperplasia, the external
jugular vein graft of the New Zealand White rabbit, rarely
develops more than about 100 µm of thickening after 4
weeks, which essentially translates to less than 5% luminal
stenosis.4,7,27-32 Furthermore, the proposed relationship
between low τ and NIT does little to explain how occlu-
sive lesions develop in failing vein grafts. Reductions in
blood flow of 50% to 80% have generally led to only a
doubling of NIT,14 which still does not result in any dis-
cernible encroachment on the lumen. With a linear extrap-
olation of these findings, a 99% reduction in flow would
still result in < 20% stenosis, a finding generally not asso-
ciated with graft failure. Moreover, because τ will tend to
increase and stabilize as diameter decreases, it seems even
less likely that the runaway progression of an intimal
hyperplastic lesion can simply be explained by the slow
continual and linear deterioration of shear.
The hypothesis tested in this experiment is that the
relationship between τ and NIT is nonlinear and that pro-
foundly abnormal global or local τ (< 2 dyne/cm2) would
lead to SMC proliferation and NIT beyond that predicted
by a linear correlation. A vein patch model was chosen, in
deference to vein grafts, in hopes that patch angioplasty
would create less trauma and redundancy, thus tending to
maintain patency. This proved to be the case, as a 4-week
patency rate of 80% was achieved in vein patches with
mean flow rates less than 1 mL/min. The final histologic
results revealed that these profound reductions in flow and
τ stimulated an intense and sustained cellular response.
Even after 2 weeks, nearly 20% of the SMCs were still
cycling as evidenced by PCNA labeling, whereas previous
studies have documented complete attenuation of cell
cycle entry by this time period.4,33 By 4 weeks cell cycling
had abated, and an occlusive lesion had developed, albeit
with only about 30% stenosis, with contributions from
both the venous and arterial sides of the patch. In some
patches, luminal thrombus was also evident, although this
seemed to slightly attenuate the proliferative response.
The findings reported herein are supported by several
related studies. Morinaga et al1,5 were able to profoundly
reduce flow in canine vein grafts (from about 80 to 3
mL/min), and the patent grafts exhibited pronounced
thickening, enhanced nearly ninefold. Somewhat surpris-
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ingly, the common carotid artery of the mouse can remain
patent even after complete ligation, and several investiga-
tors have reported that the subsequent hyperplastic
response nearly occludes the artery.34-36 Finally, very low
levels of shear (< 2 dyne/cm2) can be maintained in vitro,
and these lead to a variety of pathologic endothelial cellu-
lar events including hyperpolarization, adhesion molecule
expression, intracellular calcium release, downregulation
of prostaglandin I2 and nitric oxide synthase, and platelet-
derived growth factor production.37-39
In summary, the results presented herein suggest that
the relationship between τ and NIT in vein grafts is non-
linear and that very low shear leads to SMC activation,
proliferation, and hyperplasia far exceeding that predicted
by a linear model. The nonlinear nature of the cellular
proliferative response and NIT at τ less than 2 dyne/cm2
may explain the seemingly rapid progression of neointimal
lesions in failing bypass grafts.
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DISCUSSION
Dr Thomas Huber (Gainesville, Fla). I had the opportunity
to review the manuscript in advance, and the authors have asked
me to initiate the discussion. Overall, I would like to commend
them on the quality of their study, the presentation, and the man-
uscript itself. I have one technical question, and then I would like
to ask them to translate to the clinical arena.
First, although I do not doubt that their model induced a
low shear stress and a high shear stress, I am somewhat concerned
by their measurements. Dissecting normal carotid arteries initiates
a fair amount of vasospasm, and I would like to have them com-
ment on the accuracy of their flow and diameter measurements in
that setting.
Second, I would like to ask them to provide their working
hypothesis of lower extremity vein graft stenoses. Are the low
shear stress measurements that they see in their model consistent
with the vein graft? Also, we usually think of a failing graft as a
focal problem rather than a diffuse problem. I would like to have
them explain the impact of low shear stress in terms of a focal
stenosis rather than a diffuse stenosis.
Dr Shari Meyerson. In answer to the first question, measure-
ments of flow and diameter are obviously very sensitive to
vasospasm. For this reason the carotid artery and the completed
vein patch were bathed with papaverine in an attempt to reduce
any spasm prior to measurements. A significant increase in flow
was demonstrated after the application of papaverine.
The applicability of this model to vein grafts is, of course, the
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key to this study. We have done some work looking at models of
shear stress in clinical vein grafts and have found that the levels of
shear stress we are producing in this rabbit model are similar to
what is seen in patient vein grafts. Obviously, the vein graft does
not fail because of thickening throughout its length; instead, it is
a focal process that is seen clinically. It is felt that localized areas
of extremely low shear stress such as those created in this model
may be triggered by preexisting problems with the graft—intimal
defects leading to disruption of flow and turbulence. Therefore,
this research may explain the progression of stenosis rather than
the initial inciting event.
Dr Timothy Liem (Columbia, Mo). I enjoyed your paper
very much. I have two comments.
One comment is with regard to the measurement of shear
stress. It is a very difficult thing to measure in vivo. To use the
equation that you showed, you have to assume that there is steady
flow, laminar, and fully developed flow. When you have oscillatory
flow, that puts in a whole different picture, so that is actually not
an accurate measurement per se of the shear stress. I think it is a
pretty good approximation, but I do not think it is an exact num-
ber for shear stress.
The other question I had was with regard to some of the
mediators of low shear–induced intimal hyperplasia. We are mea-
suring nitric oxide, which is a potent protectant, and endothelin,
which is an agent that promotes damage induced by low shear.
Have you been measuring nitric oxide or endothelin or some of
the other mediators?
Thank you.
Dr Meyerson. To answer your second question first, we have
not looked at nitric oxide. However, we have looked at some of
the other pathways and are specifically interested in the MAP
kinases and how shear stress is mediated through those pathways.
That is an area of ongoing work in our lab.
To address the measurement of shear stress, this is a mean
shear stress value and obviously does not account for the oscilla-
tory flow. We have used mathematical modeling to estimate the
oscillatory flow components and found that they were not more
representative of what was happening with these vein patches
than simple mean flow in this model.
Dr Howard Greisler (Maywood, Ill). First let me say congrat-
ulations. It was an excellent presentation and obviously a well-
deserved Guthrie Award. It is a very innovative approach, I think.
It is unusual to have the opportunity in an in vivo chronic model
to assess events that occur in ultralow shear and therefore it is an
important study, and I also would like to thank you for sharing the
manuscript with me. I recommend it to everyone to read. I do
have several, I believe it is four, specific questions for you.
First off, it is difficult at best to isolate a single physical force
as you are attempting to do with shear, and given that this is a
model of patch angioplasty, it may not necessarily be relevant to
tubular constructs such as vein grafts or other grafts, particularly
in the area of the anastomosis. In this patch angioplasty model
you are probably also altering stress strain relationships affecting
particle dwell time and mass transfer characteristics that are rele-
vant to myointimal hyperplasia. I wonder if you could address
that issue and perhaps you have used computational modeling or
other techniques to try to assess the relative contribution of those
various events.
Second, you have postulated based on your data, and you
may well be correct that the reduction in shear leads to myointi-
mal thickening, which leads to thrombus deposition. However,
by necessity in an in vivo study you cannot interrogate all time
points, particularly all early time points. Perhaps it is the chicken
and the egg; maybe your shear reduction led to mural thrombus
deposition, which in turn led to more neointimal thickening.
Perhaps you could comment on that.
Third, I just want to call your attention to one data point that
I am a little concerned about in the table or the graph that is pub-
lished in the abstract book. There is a single outlying data point
at the very low shear, very high thickness quadrant of that. Have
you recalculated your data by chance excluding that single data
point, and if so, are your conclusions the same?
Finally among the four, I promised I would stop at four, just
to remind everyone that this is an important model but it is a
model of acute change in shear and there are a lot of data with ex
vivo flow loop studies, Lowell Langville, Larry McIntyre, Gene
Sprague, a lot of people, showing specific cellular responses to
step changes in shear as opposed to changes that are gradual and
in our vein graft setting, we frequently are dealing with gradual
change in shear along with gradual encroachment of the lumen.
Can you speculate on whether your conclusions would be the
same in a gradual shear reduction model? Do you have such a
model—I sure do not—and can you envision a model being
developed to address that important issue?
Again, congratulations. It is a well-deserved award.
Dr Meyerson. Let me start out by answering some of the
more technical questions. That outlying point in the graph con-
cerned us as well; however, excluding that point did not change
the conclusions at all.
We did have two animals that I did not present in the talk
that thrombosed these patches, and we had several animals that
had a layer of thrombus in addition to the neointimal thickening.
One of the trends that we found that was interesting was that in
animals with thrombus present there tended to be actually less
neointimal thickening.
The physical forces that are applied to a vein patch are obvi-
ously different than those that are applied to a tubular vein graft,
and there is going to be some redistribution of the strain around
the lumen of the graft because the arterial portion is more com-
pliant than a vein graft at systemic pressures. We did look at some
wall tension calculations and found that wall tension did not cor-
relate with thickening in the patches.
Finally, regarding the effect of the acute change of shear, we
do not presently have a model of chronic slow increases in shear
that would perhaps be more relevant to what happens in a vein
graft. Perhaps as we try to develop further models of chronic
changes in shear stress, we will be able to shed more light on the
progression of stenosis.
